Australia markets closed

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.23+0.14 (+2.30%)
At close: 4:00PM EDT
6.25 +0.02 (+0.32%)
After hours: 05:48PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5476.62M
Enterprise value 3404.72M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)28.45k
Price/book (mrq)4.08
Enterprise value/revenue 326.98k
Enterprise value/EBITDA 7-8.70

Trading information

Stock price history

Beta (5Y monthly) -0.75
52-week change 3159.58%
S&P500 52-week change 333.64%
52-week high 37.35
52-week low 32.25
50-day moving average 35.76
200-day moving average 34.06

Share statistics

Avg vol (3-month) 32.15M
Avg vol (10-day) 3694.7k
Shares outstanding 578.34M
Implied shares outstanding 6N/A
Float 852.03M
% held by insiders 19.41%
% held by institutions 171.91%
Shares short (29 Sept 2021) 42.49M
Short ratio (29 Sept 2021) 40.48
Short % of float (29 Sept 2021) 4N/A
Short % of shares outstanding (29 Sept 2021) 43.18%
Shares short (prior month 30 Aug 2021) 4694.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Aug 2019
Ex-dividend date 4N/A
Last split factor 2277:1000
Last split date 318 Aug 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-321,706.67%

Management effectiveness

Return on assets (ttm)-23.75%
Return on equity (ttm)-39.46%

Income statement

Revenue (ttm)15k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)0.00%
Gross profit (ttm)15k
EBITDA N/A
Net income avi to common (ttm)-46.78M
Diluted EPS (ttm)-0.67
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)72.33M
Total cash per share (mrq)0.92
Total debt (mrq)431k
Total debt/equity (mrq)0.37
Current ratio (mrq)7.99
Book value per share (mrq)1.49

Cash flow statement

Operating cash flow (ttm)-40.22M
Levered free cash flow (ttm)-23.89M